Robert F. Apple, President & CEO at ANTARES PHARMA, INC. (ATRS), sold 40,000 shares at $3.00 ($120K) on 2017-04-04, disclosed to the SEC on 2017-04-05.
Open-market sale of $120k ATRS by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.00 | 37,000 | $111K | 92.5% |
| 2 | $3.00 | 3,000 | $9K | 7.5% |
| Total | $3.00 avg | 40,000 | $120K | 100% |
| Filing → |
| ATRS | SELL | 2019-12-11 | $2.0M | — | Filing → |
| ATRS | SELL | 2018-08-23 | $161K | — | Filing → |
| ATRS | BUY | 2016-03-18 | $43K | — | Filing → |